National
NAACP president: Marriage is ‘civil rights issue of our times’
Benjamin Todd Jealous described marriage as the “civil rights issue of our times.”
NAACP President Benjamin Todd Jealous speaks at his organization's national headquarters in Baltimore on Monday. (Washington Blade photo by Michael K. Lavers)
BALTIMORE – The leader of the National Association for the Advancement of Colored People stressed on Monday that his organization’s support of marriage for gays and lesbians is consistent with its broader mission to fight discrimination.
“We make this statement today because it is the legacy and responsibility of the NAACP to speak up on the civil rights issue of our times,” said NAACP President Benjamin Todd Jealous during a press conference at the organization’s national headquarters. “We are both proud of our history and challenged by it—challenged to never allow threats to equality for all people under the law to go uncontested.”
Jealous’ comments came two days after the NAACP Board of Directors endorsed extending marriage rights to same-sex couples during their quarterly meeting in Miami. Jealous became emotional as he discussed his parents who had to get married in the District of Columbia in 1966 because Maryland did not allow interracial marriage—the U.S. Supreme Court struck down this ban in Loving v. Virginia the following year. He noted that Mildred Loving herself spoke out in support of extending marriage rights to same-sex couples before she passed away.
NAACP Board of Directors Chair Roslyn M. Brock defends her organization's support of marriage equality in Baltimore on Monday (Washington Blade photo by Michael K. Lavers)
“We want to be on the record that the NAACP now firmly opposes all efforts to restrict marriage equality,” said Jealous. “We will oppose threats to the Fourteenth Amendment guarantee of equal rights under the law in any state where this issue is raised.
Jealous dismissed reports that several board members voted against the marriage resolution. Roslyn Brock, chair of the NAACP National Board of Directors, said members had an “open, honest and candid conversation” about the issue during executive sessions.
“The conversation was dispassionate, it was respectful and it embraced and respected the views of all the members who sat around the table,” she said. “This is not a religious issue or a moral issue for the NAACP. That is not the role of the NAACP. On the constitutionality of the issue, the NAACP’s National Board of Directors voted overwhelmingly to support this issue.”
In spite of this support, Brock conceded that there are board members and other NAACP members whose positions on marriage continue to evolve.
“This conversation is one, as President Jealous has stated, is taking place or has taken place across the nation,” she said. “We will work together with our units and with our board to have the courageous conversations that are necessary around this issue.”
The NAACP’s endorsement of marriage rights to same-sex couples comes less than two weeks after North Carolina voters approved a constitutional amendment that defines marriage as between a man and a woman. Doctor William Barber II, president of the North Carolina NAACP, was among those who spoke out against the ballot measure before it passed by a 61-39 percent margin.
President Barack Obama on May 9 publicly backed the issue for the first time during a White House interview with ABC News’ Robin Roberts.
“For the black community, the president of the United States is as close to Martin Luther King in terms of moral leadership,” said Sharon Lettman-Hicks, executive director of the National Black Justice Coalition, in response to a question about whether Obama’s support of marriage rights for same-sex couples prompted the NAACP’s position. “It’s not just amazing that we have a black president but that he exemplifies exceptional leadership. From a space of cultural connection more than anything else, the president stood up beyond popularity, beyond the norm, beyond status quo and took the courageous step on behalf of the LGBT community that many would have seen as a political risk. I see it as nothing less than courageous leadership.”
Maryland Gov. Martin O’Malley in March signed a bill that will allow same-sex couples to marry, but state voters will likely face a November ballot referendum that would overturn the law that is slated to take effect on Jan. 1.
Fifty-two percent of respondents who participated in a Marylanders for Marriage Equality poll in March said they would vote for the same-sex marriage bill in the likely ballot measure.
Jealous stressed during the press conference that civil rights organizations remain united against the Maryland referendum and other similar measures across the country.
“Ballot measures like that on the ballot here in Maryland are intended to encode discrimination, codify discrimination into law and therefore stand apart from our nation’s recent decades and decades and decades and decades of using its constitution… to expand rights to people,” he said. “This is a cynical attempt to use a state constitution to restrict rights and we will oppose it as we have said in our statement.”
Gerald Stansbury, president of the Maryland State Conference NAACP, told the Blade after the press conference that his affiliate has not “had much discussion” yet on the likely referendum. He suggested, however, that the civil rights organization’s endorsement of marriage rights for same-sex couples will help black voters better understand ballot measure and its potential impact on LGBT Marylanders.
“We’re hoping that Maryland will understand that any person has a right to be protected under the law,” said Stansbury. “This is basically where we’re coming from. We’re supporting the national office and the national NAACP and taking the position that they have this weekend.”
Maryland Del. Mary Washington (D-Baltimore City) also welcomed the NAACP’s position.
“As a life long member, I am encouraged by this historic decision of national NAACP to transform their position which opposed efforts to ban civil recognition of same-sex unions to one which honors and is inclusive of our black LGBT community by supporting the struggle for full marriage equality for same gender loving couples,” she told the Blade. “For those African American people who were on the fence about the issue, the support of the NAACP and our president will help move the conversation forward.
Washington categorized the endorsement as an “important step” that bolsters the efforts of those fighting against the likely referendum. Lettman-Hicks stressed that the NAACP could play a crucial role in organizing opposition to the ballot measure much like it did in North Carolina.
“The same energy that we saw in North Carolina would be monumental to the state of Maryland,” she said. “I hope that the leadership the NAACP showed on the national level will manifest at the same magnitude in Maryland especially since they’re headquartered there.”
Washington conceded these efforts would not have much of an impact among white protestants and Roman Catholics who oppose marriage rights for same-sex couples.
“Our work in those communities should continue more vigorously now than ever before,” she said.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
Advocates say MTG bill threatens trans youth, families, and doctors
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Far-right José Antonio Kast elected Chile’s next president
Lighting candles in a time of exhaustion
In real estate, trust the process
-
Politics2 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia2 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Chile5 days ago
Far-right José Antonio Kast elected Chile’s next president
-
Opinions3 days ago
Lighting candles in a time of exhaustion
